Cite
HARVARD Citation
Sirivichayakul, C. et al. (2022). Long-term Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Children and Adults: A Randomized, Placebo-Controlled, Phase 2 Study. Journal of infectious diseases. pp. 1513-1520. [Online].